ARTL
Artelo Biosciences Inc
NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY
$3.49
+2.35% today
Updated 2026-04-30
Market cap
$3.27M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.56
Dividend yield
—
52W range
$3 – $86
Volume
4.2M
Artelo Biosciences Inc (ARTL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1,625.00%
ROA
-190.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-15269.00 | — | — | — |
| 2015 | $0.00 | $-15241.00 | — | — | — |
| 2016 | $0.00 | $-29690.00 | — | — | — |
| 2017 | $0.00 | $-234889.00 | — | — | — |
| 2018 | $0.00 | $-2.34M | — | — | — |
| 2019 | $0.00 | $-2.17M | — | — | — |
| 2020 | $0.00 | $-4.66M | — | — | — |
| 2021 | $0.00 | $-7.44M | — | — | — |
| 2022 | $0.00 | $-10.08M | — | — | — |
| 2023 | $0.00 | $-9.29M | — | — | — |
| 2024 | $0.00 | $-9.83M | — | — | — |
| 2025 | $0.00 | $-12.88M | — | — | — |